iHEA

International Health Economics Association

8th World Congress: Transforming Health and Economics

Advertisement: 8th World Congress: Transforming Health and Economics

« Getting the Best Out of Search Filters | Main | Discrete Choice Modeling: Short Course »

June 25, 2012

Biopharmaceutical Pricing and Market Access Strategy Programme: University of Cambridge

Location: Cambridge, England, UK
Date: June 25 to 29, 2012

The aim of this course is to provide pharma executives with a detailed understanding of and a practical introduction to the complex discipline of pricing and market access strategy. The course will demonstrate how an informed and strategic approach can help not only to capture a higher proportion of the value of a biopharmaceutical product but also to increase the overall intrinsic value of a novel drug.

What will be taught?

Participants in this programme will:

Understand the foundations of value based pricing Learn how pricing strategy integrates with the overall product strategy in creating and capturing the value of an innovation Appreciate how health economics and outcomes research can support and complement the deployment of a pricing strategy Build a toolkit to develop and sustain the value of a product Learn specific techniques to communicate the value of a new product Formulate best practice in the field of biopharmaceutical pricing

Further details can be found on the course website.

For more information please contact:

Dr Linda Allan: lma31@cam.ac.uk
Ms Bami Oshinowo: boshinowo@pricespective.com

permalink June 2012: Short Course

Contact

iHEA 902-461-4432
902-461-IHEA

Tom GetzenExecutive Director and CEO
215-242-1196

Bill SwanDeputy CEO